查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1889517

2025年全球近患者分子解决方案市场报告

Near-Patient Molecular Solutions Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，床边分子检测解决方案市场发展迅速，预计将从2024年的41.3亿美元成长到2025年的45.4亿美元，复合年增长率达10.0%。推动这一增长的因素包括：对感染疾病快速诊断的需求不断增长、传染病日益流行、对分散式医疗服务模式的日益重视、公共卫生系统内就地检验项目的普及、中低收入国家医疗服务覆盖范围的扩大以及人们对疾病早期检测意识提升。

预计未来几年，床边分子检测解决方案市场将维持强劲成长，到2029年市场规模将达到66.56亿美元，复合年增长率（CAGR）为9.6%。预测期内的成长预计将受到以下因素的推动：慢性病和新兴感染疾病的增加、精准医疗方法的日益普及、床边检测与基层医疗网络的整合程度不断提高、政府加强诊断基础设施的倡议激增、社区和居家检测模式的扩展，以及为支持更广泛的诊断服务而增加的医疗保健支出。预测期间的关键趋势包括：微流体晶片设计的技术进步、多重分子检测平台的进步、携带式到结果分析仪的创新、互联数据报告系统的发展、即时试剂小型化研发以及全自动床边分子检测工作流程的创新。

预计未来几年，对家用照护现场设备的需求不断增长将推动近患者分子检测解决方案市场的发展。这些家用照护现场设备是由患者或非检查室人员在家中或附近操作的诊断检测系统，能够在传统中心实验室之外，更接近医疗现场进行检体采集、分析和结果解读。家用照护现场设备的日益普及源于消费者对便利、快速且易于取得的健康监测的需求，这种需求超越了传统的医疗机构。近患者分子检测解决方案与这些设备相辅相成，提供准确、快速且便携的分子检测，适用于标准实验室环境以外的检测。例如，2023年2月，美国食品药物管理局（FDA）发布了关于新冠病毒检测的最新信息，报告称已颁发1项分子处方家用检测试剂盒的紧急使用授权（EUA）、2项抗原处方笺家用检测套组的紧急使用授权、26项抗原处方笺处方（OTC）家用检测套组检测套组的紧急使用授权以及4项分子使用检测套组的紧急使用授权。因此，对家用照护现场设备的需求不断增长，推动了床边分子解决方案市场的成长。

近患者分子检测解决方案市场的主要企业正致力于整合先进技术，例如恒温核酸增幅，以提高检测效率、便携性和诊断准确性。恒温核酸增幅是一种分子技术，可在恆温条件下扩增目标核酸序列，无需传统聚合酵素链锁反应(PCR) 检测所需的热感加热。这使得分子检测能够快速、灵敏且方便。例如，2023 年 6 月，专注于分子检测的美国医疗技术公司 Cue Health 的 Cue COVID-19 分子检测套组获得了 FDA 的上市核准。这款采用等温扩增技术的诊断设备专为居家和即时检测 SARS-CoV-2 RNA 而设计。该系统包括一次性试剂盒、支援蓝牙功能的读取器以及一款行动应用程序，该应用程式可指导用户完成检测过程，并在大约 20 分钟内提供检测结果。 Cue COVID-19 分子检测可提高准确分子检测的机会，缩短结果报告时间，并有助于在传统检查室环境之外做出即时健康决策。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通货膨胀、地缘政治、贸易战和关税，以及新冠疫情及其復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球近患者分子解决方案：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素与限制因素）
  • 终端用户产业分析
  • 全球床边分子解决方案市场：成长率分析
  • 全球床边分子检测解决方案市场表现：规模与成长，2019-2024年
  • 全球床边分子检测解决方案市场预测：规模与成长，2024-2029年，2034年
  • 全球床边分子解决方案：潜在市场规模 (TAM)

第六章 市场细分

  • 全球床边分子解决方案市场按产品类型、性能和预测划分，2019-2024年、2024-2029年、2034年
  • 传染病检查试剂盒
  • 尿液检查试剂盒
  • 肿瘤标记或癌症标记
  • 妊娠和不孕症治疗
  • 血液检测套组
  • 血糖监测套件
  • 药物滥用检测套组
  • 凝血监测试剂盒
  • 心血管代谢监测套件
  • 其他的
  • 全球床边分子解决方案市场：依技术、性能和预测划分，2019-2024年、2024-2029年、2034年
  • 基于聚合酵素链锁反应（PCR）
  • 基于基因序列分析
  • 基于杂合反应
  • 基于微阵列
  • 全球床边分子解决方案市场（按最终用户、性能和预测划分，2019-2024年、2024-2029年、2034年）
  • 医院和诊所
  • 门诊治疗中心
  • 研究所
  • 居家医疗环境
  • 其他的
  • 全球床边分子检测解决方案市场：传染病检查试剂盒细分市场，按类型划分，实际数据和预测数据，2019-2024年、2024-2029年、2034年
  • 肝炎检测套组
  • 人类免疫力缺乏病毒检测套组
  • 流感检测套组
  • 新冠病毒检测套组
  • 全球床边分子检测解决方案市场：尿液检查试剂盒细分市场，按类型、性能和预测，2019-2024年、2024-2029年、2034年
  • 蛋白质检测套组
  • 血糖检测试剂盒
  • 酮体检测套组
  • 亚硝酸盐检测套组
  • 全球床边分子检测解决方案市场：肿瘤或癌症标记细分市场，按类型划分，实际数据和预测数据，2019-2024年、2024-2029年、2034年
  • 摄护腺特异性抗原检测套组
  • 癌胚抗原检测套组
  • 癌症抗原125检测套组
  • 胎儿球蛋白检测套组
  • 全球床边分子解决方案市场：生育和不孕症细分市场，按类型、性能和预测，2019-2024年、2024-2029年、2034年
  • 排卵检测套组
  • 早期怀孕检测套组
  • 电子检测套组
  • 家用不孕症治疗监测套装
  • 全球床边分子检测解决方案市场：血液检测套组细分市场，按类型、性能和预测，2019-2024年、2024-2029年、2034年
  • 血液常规检查检测套组
  • 血红素检测套组
  • 白血球计数试剂盒
  • 血小板计数测量试剂盒
  • 全球床边分子解决方案市场：血糖监测套件细分市场，按类型、性能和预测（2019-2024年、2024-2029年、2034年）
  • 血糖自测套装
  • 连续血糖监测套件
  • 非侵入性血糖检测套组
  • 免洗血糖试纸
  • 全球床边分子检测解决方案市场：药物滥用检测套组细分市场，按类型划分，实际数据和预测数据，2019-2024年、2024-2029年、2034年
  • 尿液药物检测套组
  • 唾液药物检测套组
  • 毛髮毒品检测套组
  • 血液药物检测套组
  • 全球床边分子解决方案市场：凝血监测试剂盒细分市场，按类型、性能和预测（2019-2024年、2024-2029年、2034年）
  • 凝血酶原时间检测套组
  • 国际标准化比率 (INR) 测量套件
  • 活化部份凝血活酵素时间检测套组
  • D-二聚体检测套组
  • 全球床边分子解决方案市场：心臟代谢监测套件细分市场，按类型、性能和预测（2019-2024年、2024-2029年、2034年）
  • 胆固醇检测套组
  • 三酸甘油酯检测套组
  • 低密度脂蛋白检测套组
  • 高密度脂蛋白检测套组
  • 全球床边分子解决方案市场：其他细分市场、按类型划分、实际结果和预测（2019-2024 年、2024-2029 年、2034 年）
  • 过敏检测套组
  • 甲状腺功能检测套组
  • 维生素缺乏症检测套组
  • 肝臟功能检测套组

第七章 区域和国家分析

  • 全球床边分子解决方案市场：区域表现及预测，2019-2024年、2024-2029年及2034年
  • 全球床边分子检测解决方案市场：国家、绩效与预测，2019-2024年、2024-2029年、2034年

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章：德国市场

第十八章：法国市场

第十九章：义大利市场

第二十章：西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第三十章：竞争格局与公司概况

  • 近患者分子解决方案市场：竞争格局
  • 床边分子解决方案市场：公司概况
    • Bosch Healthcare Solutions GmbH
    • Roche Holding AG
    • Thermo Fisher Scientific Inc.
    • Abbott Laboratories
    • Danaher Corporation

第31章：其他领先和创新企业

  • Siemens Healthineers AG
  • Hologic Inc.
  • bioMerieux SA
  • Sysmex Corporation
  • QuidelOrtho Corporation
  • QIAGEN NV
  • DiaSorin SpA
  • OraSure Technologies Inc.
  • Molbio Diagnostics Pvt Ltd
  • Cue Health Inc.
  • Biocartis Group NV
  • Vela Diagnostics Pte Ltd
  • Co-Diagnostics Inc.
  • Hyris Ltd
  • Genedrive plc

第32章 全球市场竞争基准化分析与仪錶板

第33章 重大併购

第34章 近期市场趋势

第三十五章：具有高市场潜力的国家及其策略

  • 2029年床边分子解决方案市场：提供新机会的国家
  • 2029年床边分子解决方案市场：提供新机会的细分市场
  • 2029年近患者分子解决方案市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章附录

简介目录
Product Code: r40065

Near-patient molecular solutions are diagnostic tests that use molecular biology methods, such as deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) detection, and are performed at or near the point of care. These tests analyze small biological samples on-site rather than sending them to a central laboratory, enabling rapid and accurate identification of pathogens or biomarkers using portable or simplified instruments. By providing quick and reliable results in outpatient, emergency, or remote environments, they support timely treatment decisions and improved health outcomes.

The key product types of near-patient molecular solutions include infectious disease testing kits, urinalysis testing kits, tumor or cancer markers, pregnancy and fertility tests, hematology testing kits, glucose monitoring kits, drugs-of-abuse testing kits, coagulation monitoring kits, cardiometabolic monitoring kits, and others. Infectious disease testing kits are diagnostic tools designed to quickly detect and identify pathogens such as bacteria, viruses, or parasites in patient samples to support prompt diagnosis and treatment. The different technologies used include polymerase chain reaction (PCR)-based methods, genetic sequencing-based methods, and hybridization-based techniques, and they serve various end users such as hospitals and clinics, ambulatory care centers, research laboratories, home care settings, and others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

The near-patient molecular solutions market research report is one of a series of new reports from The Business Research Company that provides near-patient molecular solutions market statistics, including the near-patient molecular solutions industry global market size, regional shares, competitors with the near-patient molecular solutions market share, detailed near-patient molecular solutions market segments, market trends, and opportunities, and any further data you may need to thrive in the near-patient molecular solutions industry. This near-patient molecular solutions market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The near-patient molecular solutions market size has grown rapidly in recent years. It will grow from $4.13 billion in 2024 to $4.54 billion in 2025 at a compound annual growth rate (CAGR) of 10.0%. The growth in the historic period resulted from increasing demand for rapid infectious disease diagnosis, rising prevalence of communicable diseases, growing focus on decentralized healthcare delivery, a surge in point-of-care testing programs within public health systems, expansion of healthcare access in low- and middle-income countries, and rising awareness of early disease detection.

The near-patient molecular solutions market size is expected to see strong growth in the next few years. It will grow to $6.656 billion in 2029 at a compound annual growth rate (CAGR) of 9.6%. The growth in the forecast period will be driven by the increasing burden of chronic and emerging infectious diseases, rising adoption of precision and personalized medicine approaches, growing integration of near-patient testing into primary care networks, a surge in government initiatives aimed at strengthening diagnostic infrastructure, expansion of community- and home-based testing models, and rising healthcare expenditure supporting broader diagnostic accessibility. Major trends in the forecast period include technological advancements in microfluidic cartridge design, progress in multiplex molecular assay platforms, innovations in sample-to-answer portable analyzers, developments in connectivity-enabled data reporting systems, research and development in reagent miniaturization for field use, and innovations in fully automated near-patient molecular workflows.

Growing demand for home-based point-of-care devices is anticipated to drive the expansion of the near-patient molecular solutions market in the coming years. These home-based point-of-care devices are diagnostic testing systems operated by patients or non-laboratory users at or near their homes, allowing sample collection, analysis, or result interpretation outside a conventional central laboratory and close to the site of care. The increasing popularity of home-based point-of-care devices is fueled by consumer preference for convenient, rapid, and accessible health monitoring beyond traditional healthcare settings. Near-patient molecular solutions complement these devices by delivering accurate, fast, and portable molecular diagnostics suitable for use outside standard laboratory environments. For example, in February 2023, the US Food & Drug Administration (FDA) reported in its COVID-19 testing update that it had issued one Emergency Use Authorization (EUA) for a molecular prescription at-home test, two EUAs for antigen prescription at-home tests, 26 EUAs for antigen over-the-counter (OTC) at-home tests, and four EUAs for molecular OTC at-home tests. As a result, the rising demand for home-based point-of-care devices is contributing to the growth of the near-patient molecular solutions market.

Key players in the near-patient molecular solutions market are focusing on integrating advanced technologies, such as isothermal nucleic acid amplification, to improve testing efficiency, portability, and diagnostic accuracy. Isothermal nucleic acid amplification is a molecular diagnostic technique that amplifies target nucleic acid sequences at a constant temperature, eliminating the need for thermal cycling used in conventional polymerase chain reaction (PCR) methods. This enables rapid, sensitive, and compact molecular testing. For instance, in June 2023, Cue Health Inc., a US-based healthcare technology company specializing in molecular diagnostics, received FDA marketing authorization for the Cue COVID-19 Molecular Test. This isothermal amplification-based diagnostic device is designed for at-home and point-of-care detection of SARS-CoV-2 RNA. The system includes a single-use cartridge, a Bluetooth-enabled reader, and a mobile app that guides users through testing and provides results in approximately 20 minutes. The Cue COVID-19 Molecular Test enhances access to accurate molecular diagnostics, shortens turnaround time, and facilitates real-time health decision-making outside traditional laboratory settings.

In July 2024, Roche Holding AG, a Switzerland-based provider of in-vitro diagnostics and pharmaceuticals, acquired LumiraDx's point-of-care (POC) technology business for $353.5 million. This acquisition gives Roche access to LumiraDx's portable, multi-assay diagnostic platform, strengthening its decentralized and near-patient testing capabilities, expanding its presence in primary care and community settings, and improving the delivery of rapid, reliable diagnostic results outside conventional laboratories. LumiraDx Group Limited, a UK-based provider of next-generation point-of-care diagnostics, is recognized for its compact instrument that integrates immunoassay, clinical chemistry, and emerging molecular testing capabilities for near-patient applications.

Major companies operating in the near-patient molecular solutions market are Bosch Healthcare Solutions GmbH, Roche Holding AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Hologic Inc., bioMerieux SA, Sysmex Corporation, QuidelOrtho Corporation, QIAGEN NV, DiaSorin SpA, OraSure Technologies Inc., Molbio Diagnostics Pvt Ltd, Cue Health Inc., Biocartis Group NV, Vela Diagnostics Pte Ltd, Co-Diagnostics Inc., Hyris Ltd, Genedrive plc.

North America was the largest region in the near-patient molecular solutions market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in near-patient molecular solutions report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the near-patient molecular solutions market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The near-patient molecular solutions market consists of sales of sample preparation devices, nucleic acid extraction kits, portable molecular analyzers, isothermal amplification kits, microfluidic cartridges, and multiplex detection panels. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Near-Patient Molecular Solutions Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on near-patient molecular solutions market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for near-patient molecular solutions ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The near-patient molecular solutions market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product Type: Infectious Diseases Testing Kits; Urinalysis Testing Kits; Tumor Or Cancer Markers; Pregnancy And Fertility; Hematology Testing Kits; Glucose Monitoring Kits; Drugs-Of-Abuse Testing Kits; Coagulation Monitoring Kits; Cardiometabolic Monitoring Kits; Other Product Types
  • 2) By Technology: Polymerase Chain Reaction (PCR)-Based; Genetic Sequencing-Based; Hybridization-Based; Microarray-Based
  • 3) By End-User: Hospitals And Clinics; Ambulatory Care Centers; Research Laboratories; Home Care Settings; Other End-Users
  • Subsegments:
  • 1) By Infectious Diseases Testing Kits: Hepatitis Testing Kits; Human Immunodeficiency Virus Testing Kits; Influenza Testing Kits; COVID-19 Testing Kits
  • 2) By Urinalysis Testing Kits: Protein Testing Kits; Glucose Testing Kits; Ketone Testing Kits; Nitrite Testing Kits
  • 3) By Tumor Or Cancer Markers: Prostate-Specific Antigen Testing Kits; Carcinoembryonic Antigen Testing Kits; Cancer Antigen 125 Testing Kits; Alpha-Fetoprotein Testing Kits
  • 4) By Pregnancy And Fertility: Ovulation Testing Kits; Early Pregnancy Testing Kits; Digital Pregnancy Testing Kits; Home Fertility Monitoring Kits
  • 5) By Hematology Testing Kits: Complete Blood Count Testing Kits; Hemoglobin Testing Kits; White Blood Cell Count Testing Kits; Platelet Count Testing Kits
  • 6) By Glucose Monitoring Kits: Self-Monitoring Blood Glucose Kits; Continuous Glucose Monitoring Kits; Non-Invasive Glucose Testing Kits; Disposable Glucose Test Strips
  • 7) By Drugs-Of-Abuse Testing Kits: Urine Drug Testing Kits; Saliva Drug Testing Kits; Hair Drug Testing Kits; Blood Drug Testing Kits
  • 8) By Coagulation Monitoring Kits: Prothrombin Time Testing Kits; International Normalized Ratio Testing Kits; Activated Partial Thromboplastin Time Testing Kits; D-Dimer Testing Kits
  • 9) By Cardiometabolic Monitoring Kits: Cholesterol Testing Kits; Triglyceride Testing Kits; Low-Density Lipoprotein Testing Kits; High-Density Lipoprotein Testing Kits
  • 10) By Other Product Types: Allergy Testing Kits; Thyroid Function Testing Kits; Vitamin Deficiency Testing Kits; Liver Function Testing Kits
  • Companies Mentioned: Bosch Healthcare Solutions GmbH; Roche Holding AG; Thermo Fisher Scientific Inc.; Abbott Laboratories; Danaher Corporation; Siemens Healthineers AG; Hologic Inc.; bioMerieux SA; Sysmex Corporation; QuidelOrtho Corporation; QIAGEN NV; DiaSorin SpA; OraSure Technologies Inc.; Molbio Diagnostics Pvt Ltd; Cue Health Inc.; Biocartis Group NV; Vela Diagnostics Pte Ltd; Co-Diagnostics Inc.; Hyris Ltd; Genedrive plc.
  • Countries:

Table of Contents

1. Executive Summary

2. Near-Patient Molecular Solutions Market Characteristics

3. Near-Patient Molecular Solutions Market Trends And Strategies

4. Near-Patient Molecular Solutions Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Near-Patient Molecular Solutions Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Near-Patient Molecular Solutions PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Near-Patient Molecular Solutions Market Growth Rate Analysis
  • 5.4. Global Near-Patient Molecular Solutions Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Near-Patient Molecular Solutions Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Near-Patient Molecular Solutions Total Addressable Market (TAM)

6. Near-Patient Molecular Solutions Market Segmentation

  • 6.1. Global Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Infectious Diseases Testing Kits
  • Urinalysis Testing Kits
  • Tumor Or Cancer Markers
  • Pregnancy And Fertility
  • Hematology Testing Kits
  • Glucose Monitoring Kits
  • Drugs-Of-Abuse Testing Kits
  • Coagulation Monitoring Kits
  • Cardiometabolic Monitoring Kits
  • Other Product Types
  • 6.2. Global Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Polymerase Chain Reaction (PCR)-Based
  • Genetic Sequencing-Based
  • Hybridization-Based
  • Microarray-Based
  • 6.3. Global Near-Patient Molecular Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals And Clinics
  • Ambulatory Care Centres
  • Research Laboratories
  • Home Care Settings
  • Other End-Users
  • 6.4. Global Near-Patient Molecular Solutions Market, Sub-Segmentation Of Infectious Diseases Testing Kits, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hepatitis Testing Kits
  • Human Immunodeficiency Virus Testing Kits
  • Influenza Testing Kits
  • COVID-19 Testing Kits
  • 6.5. Global Near-Patient Molecular Solutions Market, Sub-Segmentation Of Urinalysis Testing Kits, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Protein Testing Kits
  • Glucose Testing Kits
  • Ketone Testing Kits
  • Nitrite Testing Kits
  • 6.6. Global Near-Patient Molecular Solutions Market, Sub-Segmentation Of Tumor Or Cancer Markers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Prostate-Specific Antigen Testing Kits
  • Carcinoembryonic Antigen Testing Kits
  • Cancer Antigen 125 Testing Kits
  • Alpha-Fetoprotein Testing Kits
  • 6.7. Global Near-Patient Molecular Solutions Market, Sub-Segmentation Of Pregnancy And Fertility, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Ovulation Testing Kits
  • Early Pregnancy Testing Kits
  • Digital Pregnancy Testing Kits
  • Home Fertility Monitoring Kits
  • 6.8. Global Near-Patient Molecular Solutions Market, Sub-Segmentation Of Hematology Testing Kits, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Complete Blood Count Testing Kits
  • Hemoglobin Testing Kits
  • White Blood Cell Count Testing Kits
  • Platelet Count Testing Kits
  • 6.9. Global Near-Patient Molecular Solutions Market, Sub-Segmentation Of Glucose Monitoring Kits, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Self-Monitoring Blood Glucose Kits
  • Continuous Glucose Monitoring Kits
  • Non-Invasive Glucose Testing Kits
  • Disposable Glucose Test Strips
  • 6.10. Global Near-Patient Molecular Solutions Market, Sub-Segmentation Of Drugs-Of-Abuse Testing Kits, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Urine Drug Testing Kits
  • Saliva Drug Testing Kits
  • Hair Drug Testing Kits
  • Blood Drug Testing Kits
  • 6.11. Global Near-Patient Molecular Solutions Market, Sub-Segmentation Of Coagulation Monitoring Kits, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Prothrombin Time Testing Kits
  • International Normalized Ratio Testing Kits
  • Activated Partial Thromboplastin Time Testing Kits
  • D-Dimer Testing Kits
  • 6.12. Global Near-Patient Molecular Solutions Market, Sub-Segmentation Of Cardiometabolic Monitoring Kits, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Cholesterol Testing Kits
  • Triglyceride Testing Kits
  • Low-Density Lipoprotein Testing Kits
  • High-Density Lipoprotein Testing Kits
  • 6.13. Global Near-Patient Molecular Solutions Market, Sub-Segmentation Of Other Product Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Allergy Testing Kits
  • Thyroid Function Testing Kits
  • Vitamin Deficiency Testing Kits
  • Liver Function Testing Kits

7. Near-Patient Molecular Solutions Market Regional And Country Analysis

  • 7.1. Global Near-Patient Molecular Solutions Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Near-Patient Molecular Solutions Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Near-Patient Molecular Solutions Market

  • 8.1. Asia-Pacific Near-Patient Molecular Solutions Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Near-Patient Molecular Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Near-Patient Molecular Solutions Market

  • 9.1. China Near-Patient Molecular Solutions Market Overview
  • 9.2. China Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Near-Patient Molecular Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Near-Patient Molecular Solutions Market

  • 10.1. India Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Near-Patient Molecular Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Near-Patient Molecular Solutions Market

  • 11.1. Japan Near-Patient Molecular Solutions Market Overview
  • 11.2. Japan Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Near-Patient Molecular Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Near-Patient Molecular Solutions Market

  • 12.1. Australia Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Near-Patient Molecular Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Near-Patient Molecular Solutions Market

  • 13.1. Indonesia Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Near-Patient Molecular Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Near-Patient Molecular Solutions Market

  • 14.1. South Korea Near-Patient Molecular Solutions Market Overview
  • 14.2. South Korea Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Near-Patient Molecular Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Near-Patient Molecular Solutions Market

  • 15.1. Western Europe Near-Patient Molecular Solutions Market Overview
  • 15.2. Western Europe Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Near-Patient Molecular Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Near-Patient Molecular Solutions Market

  • 16.1. UK Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Near-Patient Molecular Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Near-Patient Molecular Solutions Market

  • 17.1. Germany Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Near-Patient Molecular Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Near-Patient Molecular Solutions Market

  • 18.1. France Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Near-Patient Molecular Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Near-Patient Molecular Solutions Market

  • 19.1. Italy Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Near-Patient Molecular Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Near-Patient Molecular Solutions Market

  • 20.1. Spain Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Near-Patient Molecular Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Near-Patient Molecular Solutions Market

  • 21.1. Eastern Europe Near-Patient Molecular Solutions Market Overview
  • 21.2. Eastern Europe Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Near-Patient Molecular Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Near-Patient Molecular Solutions Market

  • 22.1. Russia Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Near-Patient Molecular Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Near-Patient Molecular Solutions Market

  • 23.1. North America Near-Patient Molecular Solutions Market Overview
  • 23.2. North America Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Near-Patient Molecular Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Near-Patient Molecular Solutions Market

  • 24.1. USA Near-Patient Molecular Solutions Market Overview
  • 24.2. USA Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Near-Patient Molecular Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Near-Patient Molecular Solutions Market

  • 25.1. Canada Near-Patient Molecular Solutions Market Overview
  • 25.2. Canada Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Near-Patient Molecular Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Near-Patient Molecular Solutions Market

  • 26.1. South America Near-Patient Molecular Solutions Market Overview
  • 26.2. South America Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Near-Patient Molecular Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Near-Patient Molecular Solutions Market

  • 27.1. Brazil Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Near-Patient Molecular Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Near-Patient Molecular Solutions Market

  • 28.1. Middle East Near-Patient Molecular Solutions Market Overview
  • 28.2. Middle East Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Near-Patient Molecular Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Near-Patient Molecular Solutions Market

  • 29.1. Africa Near-Patient Molecular Solutions Market Overview
  • 29.2. Africa Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Near-Patient Molecular Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Near-Patient Molecular Solutions Market Competitive Landscape And Company Profiles

  • 30.1. Near-Patient Molecular Solutions Market Competitive Landscape
  • 30.2. Near-Patient Molecular Solutions Market Company Profiles
    • 30.2.1. Bosch Healthcare Solutions GmbH Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Near-Patient Molecular Solutions Market Other Major And Innovative Companies

  • 31.1. Siemens Healthineers AG
  • 31.2. Hologic Inc.
  • 31.3. bioMerieux SA
  • 31.4. Sysmex Corporation
  • 31.5. QuidelOrtho Corporation
  • 31.6. QIAGEN NV
  • 31.7. DiaSorin SpA
  • 31.8. OraSure Technologies Inc.
  • 31.9. Molbio Diagnostics Pvt Ltd
  • 31.10. Cue Health Inc.
  • 31.11. Biocartis Group NV
  • 31.12. Vela Diagnostics Pte Ltd
  • 31.13. Co-Diagnostics Inc.
  • 31.14. Hyris Ltd
  • 31.15. Genedrive plc

32. Global Near-Patient Molecular Solutions Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Near-Patient Molecular Solutions Market

34. Recent Developments In The Near-Patient Molecular Solutions Market

35. Near-Patient Molecular Solutions Market High Potential Countries, Segments and Strategies

  • 35.1 Near-Patient Molecular Solutions Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Near-Patient Molecular Solutions Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Near-Patient Molecular Solutions Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer